Active, Not Recruiting
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
NCT04423731
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Chemotherapy Effect, Locally Advanced Pancreatic Adenocarcinoma, +1 more
- Locations
-
- Oslo University Hospital Oslo, Norway